Under chemotherapy. Encounter for antineoplastic chemotherapy
Conditions
Interventions
Intervention 1: Intervention group: Ondonestrone 0 / 1mg / kg with 2 cc normal saline plus 8 mg dexamethasone intravenously. Intervention 2: Control group: Metoclopramide 0.15 mg / kg plus 8 mg dexame
Sponsors
Shahroud University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: A definitive diagnosis of a cancer that needs chemotherapy There is no other systemic disease (such as obstructive bowel disease and gastroenteritis, central nervous system problems, and equilibrium problems) Have a previous history of chemotherapy at least three times Age range 15 to 65 years Fear and complain about severe and fairly intense nausea and vomiting in previous chemotherapy No use oral antinausea or injection medicines in the last 7 days Desire and satisfaction to enter the study
Exclusion criteria
Exclusion criteria: Use an anti-nausea and vomiting medicine for at least the past 7 days Dissatisfaction with this treatment Those who use drugs There is a severe allergic reaction to either of the two drugs, Endonestrone and Metoclopramide Dissatisfaction with cooperation and participation in the project
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of pain. Timepoint: After treatment. Method of measurement: Visual Scale.;Nausea and vomiting. Timepoint: After treatment. Method of measurement: Visual Scale.;Complication after treatment of two drugs. Timepoint: After treatment. Method of measurement: Visual Scale.;Severe nausea after treatment. Timepoint: After treatment. Method of measurement: Visual Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrshad Mousapour
Shahroud University of Medical Sciences
Outcome results
None listed